Edgewise Therapeutics Stock Price Prediction
| EWTX Stock | USD 25.08 0.07 0.28% |
Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.39) | EPS Estimate Current Year (1.49) | EPS Estimate Next Year (1.86) | Wall Street Target Price 47.125 | EPS Estimate Current Quarter (0.37) |
Using Edgewise Therapeutics hype-based prediction, you can estimate the value of Edgewise Therapeutics from the perspective of Edgewise Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Edgewise Therapeutics using Edgewise Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Edgewise using crowd psychology based on the activity and movement of Edgewise Therapeutics' stock price.
Edgewise Therapeutics Short Interest
An investor who is long Edgewise Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Edgewise Therapeutics and may potentially protect profits, hedge Edgewise Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 24.5671 | Short Percent 0.1089 | Short Ratio 7.55 | Shares Short Prior Month 6.7 M | 50 Day MA 27.7199 |
Edgewise Therapeutics Hype to Price Pattern
Investor biases related to Edgewise Therapeutics' public news can be used to forecast risks associated with an investment in Edgewise. The trend in average sentiment can be used to explain how an investor holding Edgewise can time the market purely based on public headlines and social activities around Edgewise Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Edgewise Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Edgewise Therapeutics.
Edgewise Therapeutics Implied Volatility | 1.23 |
Edgewise Therapeutics' implied volatility exposes the market's sentiment of Edgewise Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Edgewise Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Edgewise Therapeutics stock will not fluctuate a lot when Edgewise Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Edgewise Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Edgewise because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Edgewise Therapeutics after-hype prediction price | USD 25.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Edgewise contract
Based on the Rule 16, the options market is currently suggesting that Edgewise Therapeutics will have an average daily up or down price movement of about 0.0769% per day over the life of the 2025-05-16 option contract. With Edgewise Therapeutics trading at USD 25.08, that is roughly USD 0.0193 . If you think that the market is fully incorporating Edgewise Therapeutics' daily price movement you should consider acquiring Edgewise Therapeutics options at the current volatility level of 1.23%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Edgewise |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edgewise Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edgewise Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Edgewise Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Edgewise Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Edgewise Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Edgewise Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Edgewise Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Edgewise Therapeutics' historical news coverage. Edgewise Therapeutics' after-hype downside and upside margins for the prediction period are 20.86 and 29.30, respectively. We have considered Edgewise Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Edgewise Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Edgewise Therapeutics is based on 3 months time horizon.
Edgewise Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Edgewise Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Edgewise Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Edgewise Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 4.22 | 0.00 | 0.01 | 7 Events / Month | 0 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
25.08 | 25.08 | 0.00 |
|
Edgewise Therapeutics Hype Timeline
Edgewise Therapeutics is currently traded for 25.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Edgewise is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.35%. %. The volatility of related hype on Edgewise Therapeutics is about 22908.57%, with the expected price after the next announcement by competition of 25.07. About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Edgewise Therapeutics was currently reported as 5.18. The company recorded a loss per share of 1.5. Edgewise Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Edgewise Therapeutics Basic Forecasting Models to cross-verify your projections.Edgewise Therapeutics Related Hype Analysis
Having access to credible news sources related to Edgewise Therapeutics' direct competition is more important than ever and may enhance your ability to predict Edgewise Therapeutics' future price movements. Getting to know how Edgewise Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Edgewise Therapeutics may potentially react to the hype associated with one of its peers.
Edgewise Therapeutics Additional Predictive Modules
Most predictive techniques to examine Edgewise price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Edgewise using various technical indicators. When you analyze Edgewise charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Edgewise Therapeutics Predictive Indicators
The successful prediction of Edgewise Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Edgewise Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Edgewise Therapeutics based on analysis of Edgewise Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Edgewise Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Edgewise Therapeutics's related companies.
Story Coverage note for Edgewise Therapeutics
The number of cover stories for Edgewise Therapeutics depends on current market conditions and Edgewise Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Edgewise Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Edgewise Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Edgewise Therapeutics Short Properties
Edgewise Therapeutics' future price predictability will typically decrease when Edgewise Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Edgewise Therapeutics often depends not only on the future outlook of the potential Edgewise Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Edgewise Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 63.7 M | |
| Cash And Short Term Investments | 318.4 M |
Additional Tools for Edgewise Stock Analysis
When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.